The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis

Chen, XM; Rong, DD; Cai, WH; Tong, XZ; Wang, HH

Tong, XZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China.; Wang, HH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Peoples R China.

NEOPLASMA, 2021; 68 (4): 832

Abstract

Phosphatase of regenerating liver-3 (PRL-3) is recognized as a novel independent crucial driver for AML progression. Thus, the specific inhibitor of P......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索